RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)

Go back to RBC Capital Positive on BioMarin Pharma (BMRN) Following Talazoparib Sale (MDVN)
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 66.97 --0 (-0%)
Previous Close $66.97    52 Week High $108.96 
Open $66.97    52 Week Low $62.12 
Day High $66.97    P/E N/A 
Day Low $66.97    EPS $-1.27 
Volume 757       

Medivation, Inc. (NASDAQ: MDVN) Delayed: 81.44 --0 (-0%)
Previous Close $81.44    52 Week High $81.48 
Open $3852.47    52 Week Low $26.41 
Day High $81.44    P/E N/A 
Day Low $81.44    EPS $-1.03 
Volume 13,593